[EN] HETEROCYCLIC COMPOUNDS AS SOS1 INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE SOS1
申请人:[en]BEIJING INNOCARE PHARMA TECH CO., LTD.
公开号:WO2022262691A1
公开(公告)日:2022-12-22
Provided herein are heterocyclic compounds shown in Formula (I) and their pharmaceutically acceptable salts thereof suitable for inhibiting or regulating the activity of SOS1. These compounds are useful for preventing and/or treating SOS1-mediated diseases, in particular cancers. Aslo provided are methods for preparing the mentioned compounds.